HEALTH

Study in Annals of the Rheumatic Diseases bears out efficacy of Cosamin DS

BY Michael Johnsen

EDGEWOOD, Md. — Nutramax Labs announced Thursday the publication of results from an international clinical study that demonstrates the effectiveness of glucosamine hydrochloride and chondroitin sulfate — the same active ingredients found in the joint health dietary supplement Cosamin DS — in the management of joint health and wellness. The results of the MOVES (Multicentre Osteoarthritis InterVEntion trial with Sysadoa) study are published in the online edition of the peer-reviewed journal, Annals of the Rheumatic Diseases.
 
“The MOVES trial is truly an important study that provides additional evidence to support the use of glucosamine hydrochloride and chondroitin sulfate, at a daily dose of 1,500 and 1,200 milligrams, respectively, in managing joint health in a wide variety of patient populations,” stated Nicholas DiNubile, clinical associate in the Department of Orthopedic Surgery at the Hospital of the University of Pennsylvania. “This new data is especially encouraging for patients, and it reinforces my ongoing approach to long-term joint health management in my practice, particularly for people who are experiencing a significant increase in the incidence of deteriorating joint health yet wish to remain physically active.”
 
Cosamin DS is the most researched glucosamine/chondroitin joint health supplement, Nutramax stated. Cosamin DS uses FCHG49 glucosamine and TRH122 chondroitin sulfate, providing a unique combination of ingredients not found in other glucosamine/chondroitin combination dietary supplements. “I tell my patients, not all supplements are created equal – brand matters. It’s important to recommend supplements supported by extensive research like Cosamin,” DiNubile said.
 
“We were the first company to develop this combination worldwide and publish clinical studies showing its benefits for joint health. We have been conducting both human and veterinary research for over 20 years, so it’s gratifying to see studies of this magnitude that confirm our previous findings. The MOVES study further underscores the value of Cosamin DS as a safe and effective option to support joint health,” said Robert Henderson, chairman Nutramax.
 
MOVES is a multicenter, randomized, parallel-group, double-blind, controlled clinical trial that enrolled 606 patients at 42 centers in France, Germany, Poland and Spain. The study was sponsored by Bioibérica, suppliers of the chondroitin sulfate used in Cosamin DS. The study was developed as an extension of the GAIT (Glucosamine/Chondroitin Arthritis Intervention Trial) study, which showed that the combination of glucosamine hydrochloride (1,500 mg/day) and chondroitin sulfate (1,200 mg/day) was effective in a moderate to severe subgroup of patients.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

ONE Condoms taps local urban artist community to promote national HIV prevention campaign

BY Michael Johnsen

 

 
 
NEW YORK— ONE Condoms on Thursday announced the launch of a national HIV prevention campaign that features a coalition of visual artists, musicians, celebrities and public health agencies.
 
#LustforLife (onecondoms.com/lustforlife) aims to help stop the spread of HIV/AIDS in America's urban communities, where 70% of the 50,000 new HIV infections in the United States occur each year. The campaign brought together 22 graffiti and street artists who created unique works of art on full-sized STOP signs with designs promoting safer sex. The collection was curated by Billi Kid, a contemporary artist, designer and curator whose aesthetic mixes graffiti and street art sensibilities with sophisticated nods to high art, fashion and design. The campaign kicks off with a launch event for an exhibit featuring the works of art at the Urban Outfitters store in New York City's Herald Square on Friday, Feb. 6 at 6 p.m.
 
Starting with World AIDS Day (Dec. 1, 2014), the 22 designs were revealed in a social media campaign during the month of December. In partnership with Paddle8, the #LustforLife works of art will be sold in an online public auction from Feb. 6-20, in tandem with National Condom Week (Feb. 14-21, 2015), with proceeds to benefit Lifebeat, Music Fights HIV/AIDS. Lifebeat is the leading national non-profit dedicated to educating America's youth about HIV/AIDS prevention. For 22 years, Lifebeat has been on the front lines distributing safe-sex materials to millions of at-risk youth at concert venues, music festivals and clubs throughout U.S.

In the past year, Lifebeat performed outreach on many national tours including Macklemore & Ryan Lewis, Sam Smith, Mad Decent Block Party Tour, Fall Out Boy, CHVRCHES, and Romeo Santos, and major music festivals including South by Southwest, Ultra Music Festival, Electric Daisy Carnival and Electric Zoo.

 
"ONE's mission is to increase condom use by creating products and programs that make it easier to learn about, talk about and practice safer sex," stated Davin Wedel, president of Global Protection Corp., parent company of ONE. "The #LustforLife campaign sends a powerful message about the importance of safer sex to prevent the spread of HIV and AIDS in America's urban communities. We created the campaign to bring all of us — artists, health activists, community leaders and consumers — together to shine a national spotlight on this issue."
 
Wedel noted that the launch in New York will be followed by similar campaigns in other major urban communities, each with its own unique expression of unity among local artists, public figures and health organizations.
 
ONE is producing #LustforLife condom wrappers featuring eight of the STOP sign designs and will distribute millions of them through public health organizations nationwide. The company also will introduce retail 12-packs and other products showcasing the designs and will donate a portion of sales to urban outreach programs.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

BSI Products folds style into sports-wrap solution with Fun Wraps

BY Michael Johnsen

 

COLUMBIA, Md. — BSI Products on Thursday introduced Fun Wraps — elastic bandage wraps that have stylish patterns for kids and offer the support needed to help a child heal from a typical sports injury. 
 
Fun Wraps were invented and designed by Kori Mirsberger, a graphic designer and the daughter of a doctor. When Kori was 13 years old, she broke her thumb in a dance class and received a standard, beige elastic bandage. At school the next day she decided to add some flair to her bandage by drawing all over it with a marker and ended up with a wild, leopard print bandage.  
 
The stylish bandage wrap is offered in both kid (ages 7 years and older) and adult sizes and comes in a variety of colors and patterns. The bandage material stretches comfortably and is supple to the touch. It has a patented starter-loop with a Velcro closure making it easy to wrap and keep secure with no metal clips necessary.
 
Fun Wraps can be used to provide compression to ankles, wrists, knees and elbow and are great for securing cold and hot packs to the injury or sore body part, the company said. Fun Wraps are currently sold at Target.com and in stores Duane Reade, Meijer and Apple Drug. 
 
Stores and companies have the option to purchase exclusive patterns or even custom designed Fun Wraps for something a little more unique, the company noted. Choose logos or custom images to be printed on the wraps and they will come shrink wrapped and ready for sale. Visit FunWrapsBSI.com/custom-wraps/ to place a custom order. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?